CLASS ACTION UPDATE for MRCY and MD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP
Jul. 13, 2018
NEW YORK, July 13, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court; further details about the cases can be found at the links provided.
Mercury Systems, Inc. (NASDAQ:MRCY) Class Period: October 24, 2017 - April 24, 2018Lead Plaintiff Deadline: September 10, 2018
The complaint alleges that Mercury made materially false and misleading statements and/or failed to disclose that: Mercury’s decision to in-source processing was adversely impacting Mercury’s operating margins and free cash-flow generation and conversion; Mercury’s model was becoming structurally more working capital intensive; as a result of the foregoing, Mercury’s public statements were materially false and misleading at all relevant times.
To learn more about the Mercury class action go to: http://www.zlk.com/pslra-d/mercury-systems?wire=3.
MEDNAX, Inc. (NYSE:MD)Class Period: February 4, 2016 – July 27, 2017Lead Plaintiff Deadline: September 10, 2018
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: the Company's business model was not sustainable and Mednax's growth was in fact based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections.
On April 20, 2017, Mednax announced negative financial results for the first quarter of 2017. Then on July 28, 2017, during an earnings call, Mednax announced that the Company failed to complete any acquisitions of anesthesiologist practices during the second quarter and disclosed that any future acquisitions were unlikely. Following this news, shares of Mednax fell from a close of $56.49 on July 27, 2017, to a close of $47.73 per share the following day.
To learn more about the MEDNAX class action go to: http://www.zlk.com/pslra-d/mednax-inc?wire=3.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com